Withdrawal of inhaled corticosteroids in individuals with COPD - a systematic review and comment on trial methodology

Inhaled corticosteroids (ICS) reduce COPD exacerbation frequency and slow decline in health related quality of life but have little effect on lung function, do not reduce mortality, and increase the risk of pneumonia. We systematically reviewed trials in which ICS have been withdrawn from patients w...

Descripción completa

Detalles Bibliográficos
Autores principales: Nadeem, Nighat J, Taylor, Stephanie JC, Eldridge, Sandra M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185272/
https://www.ncbi.nlm.nih.gov/pubmed/21838890
http://dx.doi.org/10.1186/1465-9921-12-107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3185272/
https://www.ncbi.nlm.nih.gov/pubmed/21838890
http://dx.doi.org/10.1186/1465-9921-12-107

Ejemplares similares